PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.91%
Revenue growth under 50% of OGI.TO's 434.55%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
229.93%
Gross profit growth above 1.5x OGI.TO's 60.52%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-19.65%
Negative EBIT growth while OGI.TO is at 58.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-19.65%
Negative operating income growth while OGI.TO is at 58.69%. Joel Greenblatt would press for urgent turnaround measures.
495.53%
Net income growth above 1.5x OGI.TO's 63.62%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
479.36%
EPS growth at 75-90% of OGI.TO's 557.14%. Bill Ackman would push for improved profitability or share repurchases to catch up.
486.45%
Diluted EPS growth at 75-90% of OGI.TO's 550.00%. Bill Ackman would expect further improvements in net income or share count reduction.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-128.34%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-5.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
231.50%
3Y revenue/share CAGR at 50-75% of OGI.TO's 402.35%. Martin Whitman would question if the firm lags behind competitor innovations.
-2712.91%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-106697.14%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-432.17%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
2364.45%
10Y net income/share CAGR of 2364.45% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
4240.51%
5Y net income/share CAGR above 1.5x OGI.TO's 1124.26%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1153.04%
Below 50% of OGI.TO's 6190.60%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
5805.96%
Equity/share CAGR of 5805.96% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
7110.93%
Below 50% of OGI.TO's 23382.03%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2546.66%
3Y equity/share CAGR above 1.5x OGI.TO's 795.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
515.88%
AR growth well above OGI.TO's 294.46%. Michael Burry fears inflated revenue or higher default risk in the near future.
55.77%
Inventory growth well above OGI.TO's 81.69%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
22.83%
Similar asset growth to OGI.TO's 21.83%. Walter Schloss finds parallel expansions or investment rates.
23.55%
Under 50% of OGI.TO's 404.82%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
78.69%
We have some new debt while OGI.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
25.44%
R&D growth of 25.44% while OGI.TO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
5.88%
SG&A declining or stable vs. OGI.TO's 30.33%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.